Remus Pharmaceuticals Ltd vs Syschem India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 715.4 as of 06 May 15:30 . The P/E Ratio of Remus Pharmaceuticals Ltd is 49.4 as of March 2024 .The P/E Ratio of Syschem (India) Ltd is 0 as of March 2024 . The Market Cap of Remus Pharmaceuticals Ltd is ₹ 1016 crore as of March 2024 .The Market Cap of Syschem (India) Ltd is ₹ 0 crore as of March 2024 . The revenue of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syschem (India) Ltd for the Dec '25 is ₹ 141.5 crore as compare to the Sep '25 revenue of ₹ 103.61 crore. This represent the growth of 36.57% The ebitda of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syschem (India) Ltd for the Dec '25 is ₹ 5.96 crore as compare to the Sep '25 ebitda of ₹ 3.31 crore. This represent the growth of 80.06% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Syschem (India) Ltd changed from ₹ 0.14 crore to ₹ 4.17 crore over 7 quarters. This represents a CAGR of 595.49% The Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 4.44 % on March 2025 . This represents a CAGR of 20.15% over 3 yearsThe Dividend Payout of Syschem (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

About Syschem (India) Ltd

Syschem (India) Limited, formerly known as Anil Pesticides Limited was incorporated on 31 December, 1993.
The name of the Company was changed from Anil Pesticides Limited to Syschem (India) Limited on February 17, 2003.
Company is engaged in the business of manufacturing of API / Intermediates.
It has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt.
Panchkula (Haryana). In 1996 the company went for launching new product called Monocrotophos and production was commissioned in 1998. The company expanded the installed capacity of Dichlorvos by 400 TPM in 2000. The company introduced new products namely Deta,DETC and Ethion in 2001.

FAQs for the comparison of Remus Pharmaceuticals Ltd and Syschem (India) Ltd

Which company has a larger market capitalization, Remus Pharmaceuticals Ltd or Syschem (India) Ltd?

Market cap of Remus Pharmaceuticals Ltd is 843 Cr while Market cap of Syschem (India) Ltd is 260 Cr

What are the key factors driving the stock performance of Remus Pharmaceuticals Ltd and Syschem (India) Ltd?

The stock performance of Remus Pharmaceuticals Ltd and Syschem (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remus Pharmaceuticals Ltd and Syschem (India) Ltd?

As of May 6, 2026, the Remus Pharmaceuticals Ltd stock price is INR ₹715.4. On the other hand, Syschem (India) Ltd stock price is INR ₹53.06.

How do dividend payouts of Remus Pharmaceuticals Ltd and Syschem (India) Ltd compare?

To compare the dividend payouts of Remus Pharmaceuticals Ltd and Syschem (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.